Industry: Biomedicine Region: France Transaction Price: USD 1 million Transaction Method: Equity Investment
Project introduction:
French cell design research company provides monoclonal antibodies with human-like characteristics for in vitro diagnosis of infectious diseases, autoimmune diseases, miscellaneous diseases and other fields.
The source of raw materials is safe and reliable. As a substitute for plas ma and human serum in disease state, it is currently used as calibrator, positive control or quality control for immunoassay.
1. Complete isotype range: immunoglobulin IgA, IgE, IgM and IgG.
2. Raw materials of calibration and quality control reagents for immunoassay
3. Customized solutions for the development and production of mAb for diagnostic kits
4. A wide range of antibodies for diagnostic support in the management of infectious diseases and autoimmune diseases or the identification and monitoring of allergies and food intolerance.
5. Thanks to our special patented technology platform, we provide 2 types of solutions and related services (epitope mapping, kinetic measurement, complementary bit ID, immunization strategy, etc.):
6. Custom solutions for the development of monoclonal antibodies and in vitro diagnostic tests
7. Standard solution. There are 55 products in our catalogue, which are used as substitutes for plas ma in disease state.
